ALNY Stock Performance and Key Statistics

ALNY has a current P/E ratio of -188.07

The ALNY stock has a trailing twelve month price-to sales (P/S) ratio of 21.72 while its price-to-book (P/B) value is 439.41.

ALNY's price-to-free-cashflow (P/FCF) ratio is -676.55, an indicator that is currently being trending upward.

Based on ALNY's recent bid, its distance from 20 days simple moving average is 19.9%. It is 24.61% apart from 50 days simple moving average, and it is 44.13% apart from 200 days simple moving average.

The 52-week high for ALNY is $402.43 which is 13.37% away from the current price level whereas the distance of that from the 52-week low of $205.87 stands at 90.53%.

The performance of ALNY stock was not encouraging with most of its significant price indicators in green. Alnylam Pharmaceuticals, Inc.(NASDAQ: ALNY) shares have moved upward +15.43% or $52.44 in the latest trading session and have gained 66.69% year-to-date (YTD). The stock has gained nearly 67.02% over the past year. After moving 52.51% over the trailing 3-month period, the stock is 40.49% higher in the 6-month period. Looking at its performance over the shorter term, it'sgained 19.59% a week and 21.79% a month.

The current 14-day RSI for ALNY stock is 82.96. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.

ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Alnylam Pharmaceuticals, Inc. (ALNY) has a 14-day ATR of 12.68.

After closing at $339.80 with 130.39M of its shares outstanding, the current enterprise value of ALNY is roughly 20.05B.

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) is up 67.02% when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of 14.84%. ALNY stock price is also up 66.69% on its value in year-to-date trading.

The number outstanding shares of ALNY is 130.39M, and of these 95.63% shares are freely available for trading. On average, ALNY stock has traded 1.59M shares per day for the past 10 days. A total of 3.27M shares changed hands during the last trading session with the average session volume of 957.33K shares.